Seeing Is Believing
with an average price target of $8.37. This is a potential upside of $8.37 (0%) from yesterday's end of day stock price of $0.
Alder BioPharmaceuticals's activity chart (see below) currently has 45 price targets and 32 ratings on display.
Analysts average stock forecasts to be materialized ratio is 5.81% with an average time for these price targets to be met of 82.33 days.
Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Sep-2019. First documented stock forecast 02-Jun-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$20
$1.12 (5.93%)
$20
5 years 1 months 23 days ago
(16-Sep-2019)
0/3 (0%)
$1.5 (8.11%)
Buy
$41
5 years 5 months 11 days ago
(28-May-2019)
0/3 (0%)
$21.83 (113.88%)
Buy
$21
$2.12 (11.23%)
$27
5 years 6 months 6 days ago
(02-May-2019)
2/11 (18.18%)
$8.76 (71.57%)
155
Buy
$28
$9.12 (48.31%)
$28
5 years 8 months 14 days ago
(25-Feb-2019)
0/5 (0%)
$13.29 (90.35%)
Hold
$15
$-3.88 (-20.55%)
$29
6 years 27 days ago
(12-Oct-2018)
1/6 (16.67%)
$1.73 (13.04%)
339
What is ALDR (Alder BioPharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ALDR (Alder BioPharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ALDR (Alder BioPharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ALDR (Alder BioPharmaceuticals)?
Which analyst is the currently most bullish on ALDR (Alder BioPharmaceuticals)?
Which analyst is the currently most reserved on ALDR (Alder BioPharmaceuticals)?